You have 9 free searches left this month | for more free features.

Locally Advanced or Metastatic Urothelial Carcinoma (1)

Metastatic Solid Tumors (1)

Recruiting (2)

phase 1 (1)

phase 2 (1)

EMD Serono Research & Development Institute, Inc. (2)

Merck KGaA, Darmstadt, Germany (1)

Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar Therapeutics (1)

m6223 (2)

avelumab (1)

bintrafusp alfa (1)

nktr-255 (1)

sacituzumab govitecan (1)

drug (2)

Industry (2)

Interventional (2)

m6223

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Oct 14, 2021

Recruiting

Oct 4, 2022